A Comparative Clinical study of dashamoolaadi ghanavati with Panchaprasritik vasti in the management of diabetic neuropathy

A Comparative Clinical evaluation of Dashamoolaadi ghanavati and panchatikta panchaprasritik Vasti in the management of madhumeha janya nadipratan shotha with special reference to Diabetic Neuropathy - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/03/064201

Enrollment

104

Registered

2024-03-15

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications Health Condition 2: E114- Type 2 diabetes mellitus with neurological complications Health Condition 3: E114- Type 2 diabetes mellitus with neurological complications Health Condition 4: E114- Type 2 diabetes mellitus with neurological complications Health Condition 5: E114- Type 2 diabetes mellitus with neurological complications

Interventions

Intervention1: Dashamoolaadi ghanavati and panchatikta panchaprasritik vasti: Group1/Interventional group1-treated with Dashamoolaadi ghanavati 500mg 2 tab BD Group2/Interventionalgroup2-treated with

Eligibility

Inclusion criteria

Inclusion criteria: Diagonosed case of diabetic neuropathy Diagonosed cases of Diabetes Mellitus type2. Patient willing to participate in the above trial and giving informed consent.

Exclusion criteria

Exclusion criteria: Cases with the co occurrence of neuropathy without diabetes mellitus Pregnant and lactating women Patient with low level of vitamin B12 Patient who took other medicines Patient with diabetic nephropathy and retinopathy

Design outcomes

Primary

Measure	Time frame
1)To evaluate the clinical efficacy of Dashamoolaadi Ghanavati and Panchatikta PanchaPrasritik Vasti in the cases of Diabetic Neuropathy (DN). Timepoint: the trial drug will be given for 3 months along with 7 days enema with 3 follow up in each month	—

Secondary

Measure	Time frame
2) To study the conventional concepts of diabetic Neuropathy (DN) & its possible correlation in Ayurveda viz. Madhumeha janya nadi pratan shotha 1) Objective assesment by,a)Nerve conduction study b) blood glucose fasting ,Post prandial , HBa1cTimepoint: 3 months treatment course will be given for 3 months & 3 follow ups before treatment after 45 days & after 3 months will be recorded	—

Countries

India

Contacts

Public ContactProf OP Singh

Banaras Hindu University

singhopbhu@gmail.com9415818732

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026